Osiris receives European Orphan Drug designation for Prochymal

[at noodls] – Osiris Therapeutics Receives Title of European Orphan Drug Designation for Prochymal® COLUMBIA, Md. – February 19, 2013 – Osiris Therapeutics, Inc. (NASDAQ: OSIR), the leading stem cell company developing … more

View todays social media effects on OSIR

View the latest stocks trending across Twitter. Click to view dashboard

See who Osiris is hiring next, click here to view